Literature DB >> 17565156

Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib.

Darren R Feldman, Andrew J Martorella, Richard J Robbins, Robert J Motzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17565156     DOI： 10.1093/jnci/djm006

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Tyrosine kinase inhibitor-induced hypothyroidism: incidence, etiology, and management.

Authors:  Rebecca L Brown
Journal:  Target Oncol       Date:  2011-11-19       Impact factor: 4.493

Review 2.  Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy.

Authors:  Francesco Torino; Salvatore Maria Corsello; Raffaele Longo; Agnese Barnabei; Giampietro Gasparini
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

3.  Interactions between thyroid disorders and kidney disease.

Authors:  Gopal Basu; Anjali Mohapatra
Journal:  Indian J Endocrinol Metab       Date:  2012-03

4.  Drug-induced immune thrombocytopenic purpura secondary to sunitinib.

Authors:  M Trinkaus; M Trudeau; J Callum
Journal:  Curr Oncol       Date:  2008-06       Impact factor: 3.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.